Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-002543
Filing Date
2011-04-05
Accepted
2011-04-05 17:03:22
Documents
1
Period of Report
2011-04-03

Document Format Files

Seq Description Document Type Size
1 c65104.html 4  
1 c65104.xml 4 7319
  Complete submission text file 0000930413-11-002543.txt   9066
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUTICALS INC. RTE 202/206 BRIDGEWATER NJ 08807
Business Address
del Campo Ralph (Reporting) CIK: 0001323683 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 11740818